---
source_pdf: "https://drive.google.com/file/d/1BsIr6M2wKmcZFPn0tN5lnePyvj0WL44a7Jli_FTX9M4/view"
drive_folder: "Portfolio/Amae"
type: portfolio
company: Amae
ingested: 2025-12-23
original_filename: "AMAE Consolidated IM.gdoc"
---

> **Original:** [View Original PDF](https://drive.google.com/file/d/1BsIr6M2wKmcZFPn0tN5lnePyvj0WL44a7Jli_FTX9M4/view)

Does clinical model work? Can they do it cost effectively?

What’s ROI for payers?

GTM?

How big can this get / $ to get there?

Why now?

Overview:

Virtue to lead a $2.25M SAFE at a $12.5M post-money.

Sam - Primary

Polaris - Gary

SAFE: drgdf

Clinical model

GC - Elemy

Acquisition / retention

Overall Patient population

$ / patient

Costs to get there

Can’t move into VBC

Creativity

State by state

Network

Moving on from there strategically state-by-state

Pros

Clinical need

Clear payer demand

Strong team

Cons

High touch

Clnical model

Acquisition

Hiring

Hard to reach purely digitally

Unclear whether to go full-risk straightaway — suspect this is the biggest issue — they just want to see revenue growth (very important to see early PMF via revenue growth for Hemant & Chris).

MOU w/ Circulo

No medicaid members

GC, Felicis, Polaris, Route66, Abel Partners, CRV, Kaden, Founders Collective, Pear, Primary, HealthVelocity

Primary - follow-up

Rachel / Ben Britt - Route 66

Health Velocity - tougher to gauge their level of interest

Polaris - following up

GC

AMV - reach out to Skip

USV -

Arch -

Norwest

Equip

BoxGroup

Not tech

Little Otter